63281 Real-World Comorbidities of Adult Patients With Prurigo Nodularis Initiating Dupilumab in the USNicholas Mollanazar, Kwinten Bosman, Danielle L. Isaman et al.|Journal of the American Academy of Dermatology|2025Cited by 1
Unveiling Fabry disease journey to diagnosis: An analysis based on two United States claims databasesAna Crespo, Roberto Araujo, Alexandra Dumitriu et al.|Molecular Genetics and Metabolism|2024Cited by 0
63307 Real-World Prevalence of Psychiatric and Sleep Disorders Among Adult Patients With Prurigo Nodularis and Prurigo Nodularis Patients Initiating Dupilumab in the USSarina B. Elmariah, Kwinten Bosman, Danielle L. Isaman et al.|Journal of the American Academy of Dermatology|2025Cited by 0
63345 Real-World Comorbidities of Adult Patients With Prurigo Nodularis Initiating Dupilumab in the US by Race/EthnicityShawn G. Kwatra, Kwinten Bosman, Danielle L. Isaman et al.|Journal of the American Academy of Dermatology|2025Cited by 0
63298 Real-World Medication Use Prior to Dupilumab Initiation Among Adult Patients With Prurigo Nodularis in the USNicholas Mollanazar, Kwinten Bosman, Danielle L. Isaman et al.|Journal of the American Academy of Dermatology|2025Cited by 0